Picture of GSK logo

GSK GSK Cashflow Statement

0.000.00%
gb flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Annual cashflow statement for GSK, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line5,2686,3885,0964,9215,308
Depreciation
Amortisation
Non-Cash Items2,355-3321,2522,4331,992
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-1,93734-773-2,098-2,826
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities8,0208,4417,9527,4036,768
Capital Expenditures-2,163-2,239-2,931-2,258-2,344
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-3,1914,4001,154-6,514749
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-5,3542,161-1,777-8,772-1,595
Financing Cash Flow Items-1,453-1,950-1,4019,089-837
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-1,840-10,132-7,589823-5,641
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash744431-1,443-394-567